|Bid||0.00 x 0|
|Ask||1,800.00 x 0|
|Day's Range||1,597.00 - 1,614.00|
|52 Week Range||1,347.50 - 1,738.57|
|Beta (5Y Monthly)||0.73|
|PE Ratio (TTM)||22.43|
|Earnings Date||Mar 24, 2022 - Mar 28, 2022|
|Forward Dividend & Yield||0.73 (4.49%)|
|Ex-Dividend Date||Oct 21, 2021|
|1y Target Est||1,703.75|
ICU Medical Inc. (NASDAQ: ICUI) announced that it has completed its acquisition of Smiths Medical from Smiths Group plc (LSE: SMIN.L). The Smiths Medical business includes syringe and ambulatory infusion devices, vascular access, and vital care products. When combined with ICU Medical's existing businesses, the combined companies create a leading infusion therapy company with estimated pro forma combined revenues of approximately $2.5 billion.
Smiths Group plc ( LON:SMIN ) insiders who bought shares over the past year were rewarded handsomely last week. The...
Most readers would already know that Smiths Group's (LON:SMIN) stock increased by 5.9% over the past three months...